FDA Gives Breakthrough Device Status to 4D Path’s Breast Cancer Diagnostic Platform
The U.S. Food and Drug Administration (FDA) has designated 4D Path’s software a breakthrough device as a possible way to achieve a faster and…
The U.S. Food and Drug Administration (FDA) has designated 4D Path’s software a breakthrough device as a possible way to achieve a faster and…